Donald Trump’s CIA pick Gina Haspel is career spymaster, oversaw secret prison

Agencies
March 14, 2018

Washington, Mar 14: President Donald Trump’s pick to be the next director of the CIA is a career spymaster who oversaw torture at a secret prison during one of the darkest chapters in the agency’s history. If confirmed, 61-year-old Gina Haspel would become the first female head of the CIA. She’s described by colleagues as a seasoned veteran with 30-plus years of intelligence experience who would lead the agency with integrity. But it’s the few years she spent supervising a secret black site that will be closely scrutinized at her confirmation hearing.

Trump announced on Tuesday that he had chosen Haspel to succeed Mike Pompeo, who is replacing ousted Secretary of State Rex Tillerson. She joined the CIA in 1985 and has been deputy director of the agency since February 2017.

Between 2003 and 2005, Haspel oversaw a secret CIA prison in Thailand where terror suspects Abu Zubayadah and Abd al Rahim al-Nashiri were waterboarded, current and former U.S. intelligence officials said. Waterboarding is a process that simulates drowning and is widely considered to be a form of torture. Haspel also helped carry out an order to destroy waterboarding videos, which prompted a lengthy Justice Department investigation that ended without charges.

Trump has said that he would reintroduce waterboarding and “a lot worse,” but there’s no indication that his decision to pick Haspel signals a desire to restart the harsh interrogation and detention program. He would face steep legal and legislative hurdles if he tried.

Sen. John McCain, R-Ariz., said Haspel must explain the nature and extent of her involvement in the CIA’s interrogation program. “Current U.S. law is clear in banning enhanced interrogation techniques,” said McCain, who was beaten as a prisoner during the Vietnam War. “Any nominee for director of the CIA must pledge without reservation to uphold this prohibition.”

Former CIA Director John Brennan declined to say what Haspel’s exact role was in the interrogation program, but he told NBC that she has a “lot of integrity” and has tried to carry out her agency duties “when asked to do difficult things in challenging times.”

Brennan predicted she would be confirmed. “Gina is a very competent professional who I think deserves the chance to take the seat,” he said. Senator Richard Burr, R-N.C., the chairman of the Senate intelligence committee, which will vote whether to confirm Haspel, said she has the “right skill set, experience and judgment” to lead the CIA.

Human rights advocates said they opposed Haspel’s promotion to the helm of the CIA. “No one who had a hand in torturing individuals deserves to ever hold public office again, let alone lead an agency,” Human Rights First’s Raha Wala said Tuesday. “To allow someone who had a direct hand in this illegal, immoral and counterproductive program is to willingly forget our nation’s dark history with torture.”

After Haspel was named deputy CIA director, the European Center for Constitutional and Human Rights asked German prosecutors to issue a warrant for her arrest over her role in the interrogations. Federal prosecutors never issued the warrant because the case lacked a connection to Germany. But the rights group’s allegations against Haspel remain part of a preliminary investigation that German authorities could revive if they receive evidence that any of the parties have links to Germany.

Last year, Haspel’s name came up during a civil lawsuit in Spokane, Washington, filed by three men who said they suffered waterboarding, beatings and sleep deprivation in the CIA interrogation program developed by former Spokane psychologists James E. Mitchell and Bruce Jessen.

Lawyers for the psychologists wanted to interview Haspel and another CIA official involved in the program, but government lawyers told the federal judge in the case that the officials and documents were protected under the state secrets privilege and making them public would threaten national security.

Haspel has been chief of station at CIA outposts abroad. In Washington, she has held several senior leadership positions, including deputy director of the National Clandestine Service.

In her current post, she worked with Pompeo to manage intelligence collection, analysis, covert action, counterintelligence and cooperation with the CIA’s foreign counterparts. In a brief statement, the former undercover officer said she was “humbled” by Trump’s confidence in her to lead the agency.

Comments

Linda Peters
 - 
Wednesday, 14 Mar 2018

I had ever read. I hope it will help a lot for all. Thank you so much for this amazing posts and keep update like this excellent article.

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 29,2020

Washington, May 29: US President Donald Trump while speaking with reporters at the White House on Thursday said that he is more liked in India than the media in his own country --the United States.

"I know. And they like me in India. I think they like me in India certainly more than the media likes me in this country, " Trump told reporters at his Oval office.

"And I like Modi (Prime Minister Narendra Modi). I like your prime minister a lot. He's a great gentleman. A great gentleman," he added further while briefing the reporters.

But when asked over ties between India and China, the US President said, "They have a big conflict going with India and China. Two countries with 1.4 billion people. Two countries with very powerful militaries. And India is not happy, and probably China is not happy."

Reiterating his offer to mediate between India and China on the border issue, Trump said that he spoke to Prime Minister Narendra Modi, who is not in "good mood" about the ongoing situation with Beijing.

However, informed sources from the Ministry of External Affairs told ANI on Friday that there has been no recent contact between Prime Minister Modi and the US President. The last conversation between them took place on April 4, 2020, on the subject of hydroxychloroquine.

Asked about his Wednesday's tweet regarding his offer to mediate between India and China, Trump said, "I would do that. If they (China and India) thought it would help." However, Trump did not clarify when did he speak to Modi.

Trump on Wednesday tweeted that he is "ready, willing and able to mediate" between India and China."We have informed both India and China that the United States is ready, willing and able to mediate or arbitrate their now raging border dispute," the US President said.

In response to Trump's mediation offer, India said on Thursday that it is engaged with the Chinese side to resolve the border issue peacefully.

India's Ministry of External Affairs spokesperson Anurag Srivastava said that the two sides have established mechanisms both at military and diplomatic levels to resolve situations that may arise in border areas peacefully through dialogue and "continue to remain engaged through these channels."

Indian and Chinese field commanders have been holding talks on de-escalating the tensions.

China has also struck a conciliatory tone on the border issue with India, saying the two countries pose no threat to each other and should resolve their differences through communication, while not allowing them to overshadow bilateral relations.

"We should never let differences overshadow our relations. We should resolve differences through communication. China and India should be good neighbours of harmonious coexistence and good partners to move forward hand in hand," said Chinese Ambassador to India, Sun Weidong, on Wednesday.

The tensions escalated between India and China following a number of confrontations between soldiers of both armies.

Troops of India and China were engaged in two face-offs in Eastern Ladakh and North Sikkim along the disputed Line of Actual Control (LAC), where troops from both sides suffered injuries early this month.

Studies over the anti-malarial drug, which is believed to cure the highly contagious coronavirus, have shown side-effects, according to the Centers for Disease Control and Prevention and the World Health Organisation. But Trump continues to defend his decision to take hydroxychloroquine saying he believes that it gives an additional level of safety.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 27,2020

LGeneva, Jun 27:: The number of confirmed coronavirus cases worldwide has risen by over 177,000 in the past 24 hours to 9.4 million and the death toll has topped 480,000, the World Health Organisation (WHO) said on Friday (local time).

On Thursday, the WHO reported 167,056 new cases and 5,336 related deaths.

The fresh daily situation report estimates the number of infections confirmed in the past 24 hours at 177,012. Further, 5,116 virus-related deaths were reported over the same period, taking the toll to 484,249.

The Americas lead the count with over 4.7 million cases, followed by Europe with more than 2.6 million.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.